Evidence map›Paper›PMID 25005251›Full record

ArticleNeuropsychopharmacology : official publication of the American College of Neuropsychopharmacology2014

Reduced dopamine transporter functioning induces high-reward risk-preference consistent with bipolar disorder.

Jordy van Enkhuizen, Brook L Henry, Arpi Minassian, William Perry, Morgane Milienne-Petiot, Kerin K Higa, Mark A Geyer, Jared W Young

Abstract read
In one paragraph

Article in Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Evidence for pro-cognitive benefits of cannabinoids in people with bipolar disorder.Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology · 2026
    Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Jordy van Enkhuizen1] Department of Psychiatry, University of California San Diego, La Jolla, CA, USA [2] Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Brook L HenryDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Arpi MinassianDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
William PerryDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Morgane Milienne-Petiot1] Department of Psychiatry, University of California San Diego, La Jolla, CA, USA [2] Division of Pharmacology, Utrecht Institute for Pharmaceutical Sciences, Utrecht University, Utrecht, The Netherlands.
Kerin K HigaDepartment of Psychiatry, University of California San Diego, La Jolla, CA, USA.
Mark A Geyer1] Department of Psychiatry, University of California San Diego, La Jolla, CA, USA [2] Research Service, VA San Diego Healthcare System, San Diego, CA, USA.
Jared W Young1] Department of Psychiatry, University of California San Diego, La Jolla, CA, USA [2] Research Service, VA San Diego Healthcare System, San Diego, CA, USA.

Funding

Neurosciences Graduate Training ProgramT32NS061847 · NINDS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Brenda L Bloodgood · 2008 to 2026
$7.7M
SENSORY GATING &HABITUATION IN SCHIZOPHRENIAR01MH042228 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BRAFF, DAVID L. · 1987 to 2015
$6.5M
Interdisciplinary Research Fellowship in NeuroAIDSR25MH081482 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MARIANA CHERNER · 2007 to 2026
$5.2M
Inhibitory Deficits in Mania and Hyperdopaminiergic MiceR01MH071916 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI GEYER, MARK A, PERRY, WILLIAM · 2004 to 2014
$4.2M
A model organism of brain circuitry and behavioral switching for bipolar disorderR01MH104344 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI YOUNG, JARED WILLIAM · 2014 to 2017
$1.7M
NIMH NIH HHS R01 MH042228NIMH NIH HHS R01-MH042228NIMH NIH HHS R01 MH071916NIMH NIH HHS R01-MH071916NIMH NIH HHS R01 MH104344NIMH NIH HHS R25 MH081482NINDS NIH HHS T32 NS061847
6 · The paper itself

Abstract

Individuals with bipolar disorder (BD) exhibit deleterious decision making, negatively impacting their lives. Such aberrant decision making can be quantified using the Iowa Gambling Task (IGT), which requires choosing between advantageous and disadvantageous options based on different reward/punishment schedules. The mechanisms underlying this behavioral deficit are unknown, but may include the reduced dopamine transporter (DAT) functioning reported in BD patients. Using both human and mouse IGTs, we tested whether reduced DAT functioning would recreate patterns of deficient decision making of BD patients. We assessed the IGT performance of 16 BD subjects (7 female) and 17 healthy control (HC) subjects (12 female). We recorded standard IGT performance measures and novel post-reward and post-punishment decision-making strategies. We characterized a novel single-session mouse IGT using C57BL/6J mice (n = 44). The BD and HC IGT performances were compared with the effects of chronic (genetic knockdown (KD; n = 31) and wild-type (n = 28) mice) and acute (C57BL/6J mice (n = 89) treated with the DAT inhibitor GBR12909) reductions of DAT functioning in mice performing this novel IGT. BD patients exhibited impaired decision making compared with HC subjects. Both the good-performing DAT KD and GBR12909-treated mice exhibited poor decision making in the mouse IGT. The deficit of each population was driven by high-reward sensitivity. The single-session mouse IGT measures dynamic risk-based decision making similar to humans. Chronic and acute reductions of DAT functioning in mice impaired decision-making consistent with poor IGT performance of BD patients. Hyperdopaminergia caused by reduced DAT may impact poor decision making in BD patients, which should be confirmed in future studies.

Indexed as

RewardRisk-TakingAdolescentAdultAnimalsBipolar DisorderConditioning, OperantDecision MakingDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsFemaleGames, ExperimentalGene Expression RegulationHumansImpulsive BehaviorIndividualityDopamine Plasma Membrane Transport ProteinsDopamine Uptake InhibitorsPiperazinesvanoxerine

Identifiers

PMID25005251
PMCPMC4229584

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.